<PAGE> 1
- --------
FORM 3
- --------
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a)
of the Public Utility Holding Company Act of 1935 or Section 30(f)
of the Investment Company Act of 1940
- ------------------------------------------------------------------------------
1. Name and Address of Reporting Person
Physica B.V.
- ------------------------------------------------------------------------------
(Last) (First) (Middle)
C.J. van Houtenlaan 36
- ------------------------------------------------------------------------------
(Street)
1381 CP Weesp The Netherlands
- ------------------------------------------------------------------------------
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/17/96
- ------------------------------------------------------------------------------
3. IRS or Social Security Number of Reporting Person (Voluntary)
- ------------------------------------------------------------------------------
4. Issuer Name and Ticker or Trading Symbol
Cadus Pharmaceutical Corporation: KDUS
- ------------------------------------------------------------------------------
5. Relationship of Reporting Person to Issuer:
(Check all applicable)
Director X 10% Owner
----- -----
Officer Other (Specify
----- ----- below)
-------------------------------------
- -------------------------------------------------------------------------------
6. If Amendment, Date of Original (Month/Day/Year)
<TABLE>
<CAPTION>
- -----------------------------------------------------------------------------------------------------------------------------------
TABLE 1 -- NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED
- -----------------------------------------------------------------------------------------------------------------------------------
1. Title of Security 2. Amount of Securities 3. Ownership Form: 4. Nature of Indirect
(Instr. 4) Beneficially Owned Direct (D) or Beneficial
(Instr. 4) Indirect (I) Ownership (Instr. 5)
(Instr. 5)
- ----------------------------------------- ---------------------------- ------------------------- -------------------------------
<S> <C> <C> <C>
Common Stock, $.01 par value 1,599,942 shares D Not Applicable
- ----------------------------------------- ---------------------------- ------------------------ -------------------------------
- ----------------------------------------- ---------------------------- ------------------------ -------------------------------
- ----------------------------------------- ---------------------------- ------------------------ -------------------------------
- ----------------------------------------- ---------------------------- ------------------------ -------------------------------
- ----------------------------------------- ---------------------------- ------------------------ -------------------------------
- ----------------------------------------- ---------------------------- ------------------------ -------------------------------
- ----------------------------------------- ---------------------------- ------------------------ -------------------------------
- ----------------------------------------- ---------------------------- ------------------------ -------------------------------
- ----------------------------------------- ---------------------------- ------------------------ -------------------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. (Over)
(Print or Type Responses) SEC 1473 (8/92)
</TABLE>
<PAGE> 2
<TABLE>
<CAPTION>
FORM 3 (CONTINUED) TABLE II -- DERIVATIVE SECURITIES BENEFICIALLY OWNED
(E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
- ------------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative Security 2. Date 3. Title and Amount of 4. Conver- 5. Owner- 6. Nature of Indirect
(Instr. 4) Exercisable and Securities Underlying sion or ship Beneficial Ownership
Expiration Date Derivative Security Exercise Form of (Instr. 5)
(Month/Day/ (Instr. 4) Price of Deriv-
Year) Deri- ative
vative Security:
Security Direct
------------------------------------------------- (D) or
Date Expira- Amount or Indirect (I)
Exercis- tion Title Number (Instr. 5)
able Date of Shares
- ------------------------------- -------- ----------- --------------- ----------- ------------ ----------- -----------------
<S> <C> <C> <C> <C> <C>
- ------------------------------- -------- ----------- --------------- ----------- ------------ ----------- -----------------
- ------------------------------- -------- ----------- --------------- ----------- ------------ ----------- -----------------
- ------------------------------- -------- ----------- --------------- ----------- ------------ ----------- -----------------
- ------------------------------- -------- ----------- --------------- ----------- ------------ ----------- -----------------
- ------------------------------- -------- ----------- --------------- ----------- ------------ ----------- -----------------
- ------------------------------- -------- ----------- --------------- ----------- ------------ ----------- -----------------
- ------------------------------- -------- ----------- --------------- ----------- ------------ ----------- -----------------
- ------------------------------- -------- ----------- --------------- ----------- ------------ ----------- -----------------
- ------------------------------- -------- ----------- --------------- ----------- ------------ ----------- -----------------
- ------------------------------- -------- ----------- --------------- ----------- ------------ ----------- -----------------
- ------------------------------- -------- ----------- --------------- ----------- ------------ ----------- -----------------
</TABLE>
Explanation of Responses:
By: /s/ DR. JAN WILLEM FREDERIK VAN INGEN July 27, 1996
-------------------------------------- ------------
Dr. Jan Willem Frederik van Ingen, Director Date
**Signature of Reporting Person
**Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note. File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, See Instruction 6 for procedure.